Washington, DC, July 5, 2012 — M3 Global Research, a leading medical market research firm, has added two senior executives to meet increasing demand for worldwide quantitative and qualitative market research solutions and products for clients in healthcare and other vertical markets. Bill Russo and David Deutsch have both joined M3 Global Research, adding over 70 years of combined experience to our growing organization.
Mr. Russo, formerly with eRewards / Research Now as EVP and Chief Panel Officer, holds an MBA from New York University and will be the President of Market Research overseeing the US and European sales, marketing and operational teams. Mr. Deutsch, formerly with Kantar and IMS, earned an MHS from Johns Hopkins University and will be Head of Syndicated Products.
“We are excited to add two industry veterans to our growing team,” said Craig Overpeck, COO of Global Research, “Bill and David are industry veterans who will enable us to continue our climb to the top of the industry.” M3 is currently the industry leader in quality medical market research with the exclusive distinction of being both MRA Verified and ISO Certified.
M3 Global Research offers access to over 2 million verified doctors and other healthcare professionals, differentiated into more than 700 subspecialties.
About M3 Global Research
M3 Global Research is the market research division of Tokyo-based M3 Inc. (JP:2413) operating globally with a proprietary healthcare professionals panel in more than 60 countries. The division was created by uniting the worldwide panels of MDLinx in the USA, EMS Research and Doctors.net.uk in Europe, and M3 companies across Asia. M3 Global Research offers a broad range of capabilities including quantitative, qualitative, and omnibus surveys utilizing call centers and in-country project managers. M3 has provided solutions for every top 20 pharmaceutical company in the world. For more information, visithttp://research.m3.com/ or email requests to firstname.lastname@example.org.